{ "@graph": [    { "@id": "http://linked.opendata.cz/resource/ATC/L",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Cytostatika a imunomodula\u010Dn\u00ED l\u00E9\u010Diva" , "@language" : "cs" } ,        { "@value" : "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/L04",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Immunosuppressants " , "@language" : "en" } ,        { "@value" : "Imunosupresiva" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L04" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/L04A",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Immunosuppressants " , "@language" : "en" } ,        { "@value" : "Imunosupresiva" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L04A" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/L04AX",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Jin\u00E1 imunosupresiva" , "@language" : "cs" } ,        { "@value" : "Other immunosuppressants " , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L04AX" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/L04AX03",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://www.w3.org/2004/02/skos/core#broaderTransitive" : [ "http://linked.opendata.cz/resource/ATC/L04AX" ,        "http://linked.opendata.cz/resource/ATC/L04A" ,        "http://linked.opendata.cz/resource/ATC/L04" ,        "http://linked.opendata.cz/resource/ATC/L" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Methotrex\u00E1t (pouze peror\u00E1ln\u00ED)" , "@language" : "cs" } ,        { "@value" : "Methotrexate" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L04AX03" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Drug hypersensitivity" , "@language" : "en" } ,        { "@value" : "L\u00E9kov\u00E1 alergie" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000010195",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "T\u011Bhotenstv\u00ED" , "@language" : "cs" } ,        { "@value" : "Pregnancy" , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000003529",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Selh\u00E1n\u00ED ledvin" , "@language" : "cs" } ,        { "@value" : "Kidney failure" , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000000575",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Koagulopatie" , "@language" : "cs" } ,        { "@value" : "Blood coagulation disorders" , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000002182",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Neutropenie" , "@language" : "cs" } ,        { "@value" : "Neutropenia" , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000002932",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Thrombocytopenia" , "@language" : "en" } ,        { "@value" : "Trombocytopenie" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000003302",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Hiv infekce" , "@language" : "cs" } ,        { "@value" : "Hiv infections" , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000001867",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Liver diseases, alcoholic" , "@language" : "en" } ,        { "@value" : "Alkoholick\u00E9 nemoci jater" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0013595",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/Ingredient" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Methotrex\u00E1t" , "@language" : "cs" } ,        { "@value" : "Methotrexate" , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPharmacologicalAction" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0008662" ,        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0007520" ,        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0011171" ,        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0028850" ,        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0000022" ,        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001471" ,        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0027742" ,        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0006057" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA.     " , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPregnancyCategory" : [ "http://linked.opendata.cz/resource/fda-spl/pregnancy-category/X" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/contraindicatedWith" : [ "http://linked.opendata.cz/resource/ndfrt/disease/N0000002182" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000001867" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000003302" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000003529" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000010195" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000000575" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000002932" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product/METHOTREXAT-EBEWE-2-5-MG-TABLETY",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProduct" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasActiveIngredient" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0013595" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "METHOTREXAT EBEWE 2,5 MG TABLETY" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L04AX03" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPregnancyCategory" : [ "http://linked.opendata.cz/resource/fda-spl/pregnancy-category/X" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMedicinalProductPackaging" : [ "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0184701" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0184702" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157119" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0184704" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0184703" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0184705" ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0000022",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Abortifacient agents, nonsteroidal" , "@language" : "en" } ,        { "@value" : "Abortiva nesteroidn\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Non-steroidal chemical compounds with abortifacient activity.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001471",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Antimetabolites, antineoplastic" , "@language" : "en" } ,        { "@value" : "Antimetabolity antitumor\u00F3zn\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Antimetabolites that are useful in cancer chemotherapy.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0006057",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Dermatologic agents" , "@language" : "en" } ,        { "@value" : "Dermatologick\u00E9 l\u00E1tky" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Drugs used to treat or prevent skin disorders or for the routine care of skin.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0007520",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Enzyme inhibitors" , "@language" : "en" } ,        { "@value" : "Enzymy - inhibitory" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0008662",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Folic acid antagonists" , "@language" : "en" } ,        { "@value" : "Kyselina listov\u00E1 - antagonist\u00E9" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Inhibitors of the enzyme, dihydrofolate reductase (TETRAHYDROFOLATE DEHYDROGENASE), which converts dihydrofolate (FH2) to tetrahydrofolate (FH4). They are frequently used in cancer chemotherapy. (From AMA, Drug Evaluations Annual, 1994, p2033)     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0011171",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Imunosupresiva" , "@language" : "cs" } ,        { "@value" : "Immunosuppressive agents" , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0027742",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Antirheumatic agents" , "@language" : "en" } ,        { "@value" : "Antirevmatika" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Drugs that are used to treat RHEUMATOID ARTHRITIS.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0028850",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Inhibitory synt\u00E9zy nukleov\u00FDch kyselin" , "@language" : "cs" } ,        { "@value" : "Nucleic acid synthesis inhibitors" , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Compounds that inhibit cell production of DNA or RNA.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0184703",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "METHOTREXAT EBEWE 2,5 MG TABLETY" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L04AX03" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC157996_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "25" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Antirevmatick\u00E9: \nAktivn\u00ED revmatoidn\u00ED artritida (RA) u dosp\u011Bl\u00FDch pacient\u016F, u kter\u00FDch je indikov\u00E1na l\u00E9\u010Dba antirevmatiky modifikuj\u00EDc\u00EDmi l\u00E9\u010Dbu (DMARD).\nPolyartritick\u00E9 formy t\u011B\u017Ek\u00E9, aktivn\u00ED juveniln\u00ED idiopatick\u00E9 artritidy (JIA), pokud odpov\u011B\u010F na nesteroidn\u00ED antirevmatika (NSAID) nebyla dostate\u010Dn\u00E1.\nAntipsoriatick\u00E9:\nT\u011B\u017Ek\u00E9 a generalizovan\u00E9 formy psoriasis vulgaris zejm\u00E9na plakov\u00E9ho typu, kter\u00E9 nemohou b\u00FDt dostate\u010Dn\u011B l\u00E9\u010Deny konven\u010Dn\u00ED terapi\u00ED, jako jsou fototerapie, PUVA a retinoidy.\nCytostatick\u00E1:\n Udr\u017Eovac\u00ED terapie u akutn\u00ED lymfatick\u00E9 leukemie.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL NOB 25X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0184701",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "METHOTREXAT EBEWE 2,5 MG TABLETY" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L04AX03" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC157996_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "50" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Antirevmatick\u00E9: \nAktivn\u00ED revmatoidn\u00ED artritida (RA) u dosp\u011Bl\u00FDch pacient\u016F, u kter\u00FDch je indikov\u00E1na l\u00E9\u010Dba antirevmatiky modifikuj\u00EDc\u00EDmi l\u00E9\u010Dbu (DMARD).\nPolyartritick\u00E9 formy t\u011B\u017Ek\u00E9, aktivn\u00ED juveniln\u00ED idiopatick\u00E9 artritidy (JIA), pokud odpov\u011B\u010F na nesteroidn\u00ED antirevmatika (NSAID) nebyla dostate\u010Dn\u00E1.\nAntipsoriatick\u00E9:\nT\u011B\u017Ek\u00E9 a generalizovan\u00E9 formy psoriasis vulgaris zejm\u00E9na plakov\u00E9ho typu, kter\u00E9 nemohou b\u00FDt dostate\u010Dn\u011B l\u00E9\u010Deny konven\u010Dn\u00ED terapi\u00ED, jako jsou fototerapie, PUVA a retinoidy.\nCytostatick\u00E1:\n Udr\u017Eovac\u00ED terapie u akutn\u00ED lymfatick\u00E9 leukemie.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 170.2799987792969 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 298.8800048828125 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL NOB 50X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0184702",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "METHOTREXAT EBEWE 2,5 MG TABLETY" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L04AX03" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC157996_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "20" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Antirevmatick\u00E9: \nAktivn\u00ED revmatoidn\u00ED artritida (RA) u dosp\u011Bl\u00FDch pacient\u016F, u kter\u00FDch je indikov\u00E1na l\u00E9\u010Dba antirevmatiky modifikuj\u00EDc\u00EDmi l\u00E9\u010Dbu (DMARD).\nPolyartritick\u00E9 formy t\u011B\u017Ek\u00E9, aktivn\u00ED juveniln\u00ED idiopatick\u00E9 artritidy (JIA), pokud odpov\u011B\u010F na nesteroidn\u00ED antirevmatika (NSAID) nebyla dostate\u010Dn\u00E1.\nAntipsoriatick\u00E9:\nT\u011B\u017Ek\u00E9 a generalizovan\u00E9 formy psoriasis vulgaris zejm\u00E9na plakov\u00E9ho typu, kter\u00E9 nemohou b\u00FDt dostate\u010Dn\u011B l\u00E9\u010Deny konven\u010Dn\u00ED terapi\u00ED, jako jsou fototerapie, PUVA a retinoidy.\nCytostatick\u00E1:\n Udr\u017Eovac\u00ED terapie u akutn\u00ED lymfatick\u00E9 leukemie.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL NOB 20X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0157119",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "METHOTREXAT EBEWE 2,5 MG TABLETY" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L04AX03" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC157996_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "50" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Antirevmatick\u00E9: \nAktivn\u00ED revmatoidn\u00ED artritida (RA) u dosp\u011Bl\u00FDch pacient\u016F, u kter\u00FDch je indikov\u00E1na l\u00E9\u010Dba antirevmatiky modifikuj\u00EDc\u00EDmi l\u00E9\u010Dbu (DMARD).\nPolyartritick\u00E9 formy t\u011B\u017Ek\u00E9, aktivn\u00ED juveniln\u00ED idiopatick\u00E9 artritidy (JIA), pokud odpov\u011B\u010F na nesteroidn\u00ED antirevmatika (NSAID) nebyla dostate\u010Dn\u00E1.\nAntipsoriatick\u00E9:\nT\u011B\u017Ek\u00E9 a generalizovan\u00E9 formy psoriasis vulgaris zejm\u00E9na plakov\u00E9ho typu, kter\u00E9 nemohou b\u00FDt dostate\u010Dn\u011B l\u00E9\u010Deny konven\u010Dn\u00ED terapi\u00ED, jako jsou fototerapie, PUVA a retinoidy.\nCytostatick\u00E1:\n Udr\u017Eovac\u00ED terapie u akutn\u00ED lymfatick\u00E9 leukemie.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasResumedMarketingDate" : [ { "@value" : "2012-11-12" , "@type" : "http://www.w3.org/2001/XMLSchema#date" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 170.2799987792969 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 298.8800048828125 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL NOB 50X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0184704",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "METHOTREXAT EBEWE 2,5 MG TABLETY" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L04AX03" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC157996_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "30" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Antirevmatick\u00E9: \nAktivn\u00ED revmatoidn\u00ED artritida (RA) u dosp\u011Bl\u00FDch pacient\u016F, u kter\u00FDch je indikov\u00E1na l\u00E9\u010Dba antirevmatiky modifikuj\u00EDc\u00EDmi l\u00E9\u010Dbu (DMARD).\nPolyartritick\u00E9 formy t\u011B\u017Ek\u00E9, aktivn\u00ED juveniln\u00ED idiopatick\u00E9 artritidy (JIA), pokud odpov\u011B\u010F na nesteroidn\u00ED antirevmatika (NSAID) nebyla dostate\u010Dn\u00E1.\nAntipsoriatick\u00E9:\nT\u011B\u017Ek\u00E9 a generalizovan\u00E9 formy psoriasis vulgaris zejm\u00E9na plakov\u00E9ho typu, kter\u00E9 nemohou b\u00FDt dostate\u010Dn\u011B l\u00E9\u010Deny konven\u010Dn\u00ED terapi\u00ED, jako jsou fototerapie, PUVA a retinoidy.\nCytostatick\u00E1:\n Udr\u017Eovac\u00ED terapie u akutn\u00ED lymfatick\u00E9 leukemie.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL NOB 30X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0184705",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "METHOTREXAT EBEWE 2,5 MG TABLETY" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L04AX03" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC157996_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "100" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Antirevmatick\u00E9: \nAktivn\u00ED revmatoidn\u00ED artritida (RA) u dosp\u011Bl\u00FDch pacient\u016F, u kter\u00FDch je indikov\u00E1na l\u00E9\u010Dba antirevmatiky modifikuj\u00EDc\u00EDmi l\u00E9\u010Dbu (DMARD).\nPolyartritick\u00E9 formy t\u011B\u017Ek\u00E9, aktivn\u00ED juveniln\u00ED idiopatick\u00E9 artritidy (JIA), pokud odpov\u011B\u010F na nesteroidn\u00ED antirevmatika (NSAID) nebyla dostate\u010Dn\u00E1.\nAntipsoriatick\u00E9:\nT\u011B\u017Ek\u00E9 a generalizovan\u00E9 formy psoriasis vulgaris zejm\u00E9na plakov\u00E9ho typu, kter\u00E9 nemohou b\u00FDt dostate\u010Dn\u011B l\u00E9\u010Deny konven\u010Dn\u00ED terapi\u00ED, jako jsou fototerapie, PUVA a retinoidy.\nCytostatick\u00E1:\n Udr\u017Eovac\u00ED terapie u akutn\u00ED lymfatick\u00E9 leukemie.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL NOB 100X2.5MG" , "@language" : "cs" } ] }] }